Glenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray for the treatment of seasonal allergic rhinitis.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3qplOZb
via IFTTT
0 comments:
Post a Comment